Kelly E. Carstens, Ph.D., is a lead computational toxicologist at UL Research Institutes’ Chemical Insights. Kelly conducts advanced computational research to support Chemical Insights’ mission of advancing human and environmental health. Her research portfolio includes analysis and interpretation of targeted bioactivity screening data, as well as integration and analysis of multiple data streams such as chemical properties, toxicokinetic models, and broad profiling assay data to address chemical safety questions using methods scalable to thousands of chemicals.

Kelly previously applied computational methods to analyze and translate neurotoxicity and developmental toxicity data into useful information for chemical safety assessment, and helped lead a publicly available database of in vitro screening assays for chemical prioritization and hazard characterization. She also worked extensively using new approach methods to understand the bioactivity of PFAS and chemical prioritization strategies. Kelly has provided scientific and technical expertise to partners and stakeholders for decision-making contexts, and her work has advanced international acceptance of in vitro bioactivity data for chemical safety. She has also contributed to numerous chemical assessments evaluating human health risks associated with chemicals found in the environment.

Kelly holds a Ph.D. in Neurobiology from the University of North Carolina at Chapel Hill and a Bachelor of Science in Biological Sciences from the University of Vermont. She has authored more than 25 peer-reviewed publications.

ORCiD: 0000-0002-1746-5379